• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 9, Issue 7
  3. Authors

Online ISSN: 2515-8260

Volume9, Issue7

Procalcitonin as a marker of infection in patients with sepsis: a prospective study

    Dr. Pandere Kaustubh Anil Dr. Virendra C. Patil

European Journal of Molecular & Clinical Medicine, 2022, Volume 9, Issue 7, Pages 5220-5229

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

Background and Objective: Sepsis is characterized by multiple organ dysfunction due to inflammation. It is generally credited to pathogenic infection, but there are several cases of non-infectious sepsis. Procalcitonin is a small protein that signals increased inflammation during sepsis. This study aims to characterize the prognostic value of procalcitonin in predicting sepsis severity and discriminating infectious and non-infectious sepsis.
Methods: We performed a prospective non-Interventional study, including 75 participants suffering from sepsis. The patients were grouped according to disease severity and their procalcitonin levels measured. The biochemical and microbiological outcomes were analyzed with respect to procalcitonin levels. Results were analyzed by the chi - square test, Kruskal-Wallis test, or Mann-Whitney test. Further, the receiver operating characteristic curve (ROC) was plotted for procalcitonin levels and type of infection and the area under the ROC curve was calculated.
Results: Procalcitonin was found to be correlated with sepsis severity (p=1.80E-09). A significant relationship was observed between procalcitonin levels and the presence of infection (p=0.03996). The area under the ROC curve of procalcitonin for determining presence of infection was 65.18%. At cut-off of 0.6494 (ng/mL) the sensitivity and specificity was found to be 69.81% and 63.63%. Moreover, the presence of methicillin resistant Staphylococcus aureus conferred increased procalcitonin than methicillin sensitive variety (p= 0.0098).
Conclusion: We show that procalcitonin is a predictor of sepsis severity. It can be used to predict the type of infection in patients of sepsis in a critical care setting.
Keywords:
    Procalcitonin sepsis Gram-negative bacteria Gram-positive bacteria
  • PDF (688 K)
  • XML
(2022). Procalcitonin as a marker of infection in patients with sepsis: a prospective study. European Journal of Molecular & Clinical Medicine, 9(7), 5220-5229.
Dr. Pandere Kaustubh Anil; Dr. Virendra C. Patil. "Procalcitonin as a marker of infection in patients with sepsis: a prospective study". European Journal of Molecular & Clinical Medicine, 9, 7, 2022, 5220-5229.
(2022). 'Procalcitonin as a marker of infection in patients with sepsis: a prospective study', European Journal of Molecular & Clinical Medicine, 9(7), pp. 5220-5229.
Procalcitonin as a marker of infection in patients with sepsis: a prospective study. European Journal of Molecular & Clinical Medicine, 2022; 9(7): 5220-5229.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 11
  • PDF Download: 22
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus